𝔖 Bobbio Scriptorium
✦   LIBER   ✦

74 Novel class I PI3K inhibitor CH5132799: disruption of the activated PI3K signaling in PIK3CA mutants confers potent antitumor efficacy

✍ Scribed by M. Yoshida; H. Tanaka; H. Tanimura; T. Fujii; K. Sakata; J. Ohwada; Y. Yoshimura; N. Ishii; O. Kondoh; Y. Aoki


Book ID
119602757
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
44 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.